Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Single-chain variable fragment (scFv) able to recognize and bind CD99 human protein
Frothable aqueous composition for use in a carpet backing composition
Lighting elements
System and method of automatic piloting for in-flight refuelling of aircraft, and aircraft comprising said system
Inkjet ink
Field device configuration system
Apparatus for merging spatial audio streams
  Randomly Featured Patents
Pb.sub.2 [M.sub.2-x Pb.sub.x ]O.sub.7-y compounds wherein M is Ru, Ir or mixtures thereof, and method of preparation
Knee keyboard
Radio frequency plasma generator
IC card and an adapter for the same
Locking device for a closure cap
Corrosion-resistant layered coatings
Inkjet printing device
Fin tube seal
Universal coupling for reaction injection molding machine
Electrochromic display device